BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 14734722)

  • 1. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
    Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
    J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.
    Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW
    J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.
    Carrega P; Bonaccorsi I; Di Carlo E; Morandi B; Paul P; Rizzello V; Cipollone G; Navarra G; Mingari MC; Moretta L; Ferlazzo G
    J Immunol; 2014 Apr; 192(8):3805-15. PubMed ID: 24646734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.
    Strowig T; Brilot F; Arrey F; Bougras G; Thomas D; Muller WA; Münz C
    PLoS Pathog; 2008 Feb; 4(2):e27. PubMed ID: 18266470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
    Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
    J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
    Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
    Int J Oncol; 1998 May; 12(5):1165-70. PubMed ID: 9538144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
    Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
    J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct requirements for IFNs and STAT1 in NK cell function.
    Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
    J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
    Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
    Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and analysis of human natural killer cell subsets.
    Ferlazzo G
    Methods Mol Biol; 2008; 415():197-213. PubMed ID: 18370156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
    Kikuchi-Maki A; Yusa S; Catina TL; Campbell KS
    J Immunol; 2003 Oct; 171(7):3415-25. PubMed ID: 14500636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties.
    Boysen P; Gunnes G; Pende D; Valheim M; Storset AK
    Dev Comp Immunol; 2008; 32(7):773-83. PubMed ID: 18177938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
    Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
    Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.